Joshua Krieger

Joshua Krieger

Harvard University

H-index: 9

North America-United States

About Joshua Krieger

Joshua Krieger, With an exceptional h-index of 9 and a recent h-index of 9 (since 2020), a distinguished researcher at Harvard University,

His recent articles reflect a diverse array of research interests and contributions to the field:

Scoring and Funding Breakthrough Ideas: Evidence from a Global Pharmaceutical Company

Evaluation and Learning in R&D Investment

How Important is Editorial Gatekeeping? Evidence from Top Biomedical Journals

Dusting Off the Old Ones: Drug Licensing to Startups, Innovation Success and Efficiency

Standing on the shoulders of science

Find and replace: R&D investment following the erosion of existing products

Missing novelty in drug development

Are Transformational Ideas Harder to Fund? Resource Allocation to R&D Projects at a Global Pharmaceutical Firm

Joshua Krieger Information

University

Position

Harvard Business School

Citations(all)

810

Citations(since 2020)

550

Cited By

444

hIndex(all)

9

hIndex(since 2020)

9

i10Index(all)

9

i10Index(since 2020)

9

Email

University Profile Page

Google Scholar

Top articles of Joshua Krieger

Scoring and Funding Breakthrough Ideas: Evidence from a Global Pharmaceutical Company

Harvard Business School Entrepreneurial Management Working Paper

2023/11/21

Joshua Krieger
Joshua Krieger

H-Index: 8

Ramana Nanda
Ramana Nanda

H-Index: 23

Evaluation and Learning in R&D Investment

2023/5/29

How Important is Editorial Gatekeeping? Evidence from Top Biomedical Journals

Review of Economics and Statistics

2023

Dusting Off the Old Ones: Drug Licensing to Startups, Innovation Success and Efficiency

Innovation Success and Efficiency (November 18, 2022)

2022/11/18

Standing on the shoulders of science

Strategic Management Journal

2022/9/8

Find and replace: R&D investment following the erosion of existing products

Management Science

2022/9

Missing novelty in drug development

The Review of Financial Studies

2022/2/1

Are Transformational Ideas Harder to Fund? Resource Allocation to R&D Projects at a Global Pharmaceutical Firm

2022

Joshua Krieger
Joshua Krieger

H-Index: 8

Ramana Nanda
Ramana Nanda

H-Index: 23

Trials and terminations: Learning from competitors’ R&D failures

Management Science

2021/9

Private and social returns to R&D: drug development and demographics

AEA Papers and Proceedings

2021/5/1

See List of Professors in Joshua Krieger University(Harvard University)

Co-Authors

academic-engine